Back
A Systematic Review of Neoadjuvant Therapy Compared to the “Resection First” Approach for Patients with Borderline Resectable Pancreatic Adenocarcinoma
Paul G. Toomey, Sharona Ross, Shalin Shah, Alexander S. Rosemurgy
J. Cancer Ther. Vol.5 No.1, January 17, 2014  DOI: 10.4236/jct.2014.51012
       (PDF  1159K)     HTML     
Pancreatoduodenectomy with Simultaneous Venous Resection for Advanced Ductal Pancreatic Head Cancer: A Case Control Study
Philipp R. Scherber, Jurgita Mikneviciute, Gereon Gäbelein, Dorian Igna, Matthias Glanemann
Surg. Sci. Vol.9 No.11, November 12, 2018  DOI: 10.4236/ss.2018.911045
       (PDF  873K)     HTML      XML
Recent Developments and Current Issues in the Treatment of Pancreatic Cancer
Helmut Oettle
J. Cancer Ther. Vol.4 No.10, November 14, 2013  DOI: 10.4236/jct.2013.410A003
       (PDF  665K)     HTML     
A New Era in the Adjuvant Treatment of Pancreatic Adenocarcinoma
Manuela Machado, Maria Leitão, Mário Fontes e Sousa, Magalhães e Helena
J. Cancer Ther. Vol.10 No.12, December 10, 2019  DOI: 10.4236/jct.2019.1012078
       (PDF  230K)     HTML      XML
Prediction of Response to Neoadjuvant Chemotherapy in Egyptian Patients with Locally Advanced Breast Cancer: The Evolving Role of Tumour Infiltrating Lymphocytes (TILs)
Manal M. El-Mahdy, Riham A. Ibrahim, Radwa M. Hamed, Mohamaad S. Elkady, Walid A. Bayoumy, Zeinab M. Elsayed, Mai M. Ezz-El-Din
J. Cancer Ther. Vol.11 No.4, April 22, 2020  DOI: 10.4236/jct.2020.114018
       (PDF  838K)     HTML      XML
 
 
Top